COMMUNIQUÉ RÉGLEMENTÉ
News
-
-
COMMUNIQUÉ DE PRESSE
VALBIOTIS SA: Valbiotis raises awareness of cardiometabolic risks with the Cœur en Jeu prevention campaign
Valbiotis raises awareness of cardiometabolic risks with the Cœur en Jeu prevention campaign. French laboratory Valbiotis launches an awareness campaign to promote cardiometabolic health in women with the support of the foundation Agir pour le Cœur des Femmes. The campaign aims to educate, engage, and support women in reducing cardiometabolic risks -
COMMUNIQUÉ DE PRESSE
VALBIOTIS SA: Valbiotis sensibilise aux risques cardiométaboliques à travers une campagne de prévention “Coeur en jeu”
Valbiotis sensibilise aux risques cardiométaboliques avec la campagne de prévention "+Coeur en jeu+" pour les femmes, soutenue par la Fondation Agir pour le Cœur des Femmes -
-
-
-
-
COMMUNIQUÉ DE PRESSE
ABO Energy: Bondholders support restructuring
ABO Energy bondholders support company restructuring with over 99% majority votes, allowing provision of collateral for tariff tenders. Waiver of termination rights ensures ongoing restructuring progress. Joint representative appointed for negotiations -
COMMUNIQUÉ DE PRESSE
Skyhawk Therapeutics Appoints Aaron Deves as Chief Commercial Officer to Lead Commercialization of SKY-0515 for Huntington's Disease
Skyhawk Therapeutics appoints Aaron Deves as Chief Commercial Officer to drive SKY-0515 launch for Huntington's Disease. Deves brings extensive experience in launching therapies for neurological diseases -
